Warning: The NCBI web site requires JavaScript to function. more...
An official website of the United States government
The .gov means it's official. Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you're on a federal government site.
The site is secure. The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.
FILIP1 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
GEO DataSets Gene Profile neighbors Chromosome neighbors Homologene neighbors
ATP6AP1L - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
HNRNPK - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
WNK1 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
ANKRD18A - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
GEO DataSets Gene Profile neighbors Chromosome neighbors
Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
GEO DataSets Profile neighbors
ARL3 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
HNRNPU - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
SPACA7 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
CD300A - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
DNAJB7 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
KHDC1 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
IGHV5-78 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
CCDC13 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
FAM159A - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
PABPC1L - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
Filters: Manage Filters
Your browsing activity is empty.
Activity recording is turned off.
Turn recording back on